141 related articles for article (PubMed ID: 2824386)
1. Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures.
Avila-Cariño J; Torsteinsdottir S; Ehlin-Henriksson B; Lenoir G; Klein G; Klein E; Masucci MG
Int J Cancer; 1987 Nov; 40(5):691-7. PubMed ID: 2824386
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
[TBL] [Abstract][Full Text] [Related]
5. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG
Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362
[TBL] [Abstract][Full Text] [Related]
6. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
7. Induction of the lytic viral cycle in Epstein Barr virus carrying Burkitt lymphoma lines is accompanied by increased expression of major histocompatibility complex molecules.
Di Renzo L; Avila-Cariño J; Klein E
Immunol Lett; 1993 Nov; 38(3):207-14. PubMed ID: 8125529
[TBL] [Abstract][Full Text] [Related]
8. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
9. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
10. CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
Frisan T; Donati D; Cervenak L; Wilson J; Masucci MG; Bejarano MT
Int J Cancer; 1999 Dec; 83(6):772-9. PubMed ID: 10597194
[TBL] [Abstract][Full Text] [Related]
11. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
[TBL] [Abstract][Full Text] [Related]
12. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
13. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
Torsteinsdottir S; Masucci MG; Ehlin-Henriksson B; Brautbar C; Ben Bassat H; Klein G; Klein E
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5620-4. PubMed ID: 3016710
[TBL] [Abstract][Full Text] [Related]
14. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
Takimoto T; Sato H; Ogura H
Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.
Menezes J; Jondal M; Leibold W; Dorval G
Infect Immun; 1976 Feb; 13(2):303-10. PubMed ID: 177360
[TBL] [Abstract][Full Text] [Related]
16. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
17. Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
Jilg W; Voltz R; Markert-Hahn C; Mairhofer H; Münz I; Wolf H
Cancer Res; 1991 Jan; 51(1):27-32. PubMed ID: 1899042
[TBL] [Abstract][Full Text] [Related]
18. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
Avila-Carino J; Torsteinsdottir S; Bejarano MT; Klein G; Klein E; Masucci MG
Cell Immunol; 1988 Dec; 117(2):303-11. PubMed ID: 2848629
[TBL] [Abstract][Full Text] [Related]
20. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
